{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:34:04Z","timestamp":1781008444618,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA042014-24"],"award-info":[{"award-number":["5P30CA042014-24"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017094","name":"Department of Internal Medicine, University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cellimm.2021.104379","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:09:42Z","timestamp":1620734982000},"page":"104379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells"],"prefix":"10.1016","volume":"365","author":[{"given":"Tanna","family":"Wuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Huecksteadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hoidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Ostrand-Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellimm.2021.104379_b0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","author":"Steeg","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.cellimm.2021.104379_bib346","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of Melanoma: Facts and Hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cellimm.2021.104379_b0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.18632\/oncotarget.2677","article-title":"The landscape of metastatic progression patterns across major human cancers","volume":"6","author":"Budczies","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cellimm.2021.104379_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005382-198710000-00005","article-title":"Blood supply of pulmonary metastases","volume":"2","author":"Milne","year":"1987","journal-title":"J. Thorac. Imaging"},{"issue":"4","key":"10.1016\/j.cellimm.2021.104379_b0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)61184-4","article-title":"Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography","volume":"167","author":"Savai","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellimm.2021.104379_b0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","article-title":"Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche","volume":"166","author":"Clever","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2021.104379_b0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1164\/rccm.200804-592OC","article-title":"Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells","volume":"179","author":"Gereke","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellimm.2021.104379_b0040","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0045","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2021.104379_b0050","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellimm.2021.104379_b0055","first-page":"1147","article-title":"Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung","volume":"44","author":"Fehrenbach","year":"1998","journal-title":"Mol. Cell. Biol. (Noisy-le-Grand, France)"},{"key":"10.1016\/j.cellimm.2021.104379_b0060","doi-asserted-by":"crossref","unstructured":"M. Shirasawa, N. Fujiwara, S. Hirabayashi, H. Ohno, J. Iida, K. Makita, Y. Hata, Receptor for advanced glycation end-products is a marker of type I lung alveolar cells, Genes Cells, 9 (2004) 165-174.","DOI":"10.1111\/j.1356-9597.2004.00712.x"},{"issue":"11","key":"10.1016\/j.cellimm.2021.104379_b0065","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI200418704","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"Liliensiek","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104379_b0070","doi-asserted-by":"crossref","first-page":"L491","DOI":"10.1152\/ajplung.00090.2013","article-title":"The receptor for advanced glycation end-products supports lung tissue biomechanics","volume":"305","author":"Al-Robaiy","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"47","key":"10.1016\/j.cellimm.2021.104379_b0075","doi-asserted-by":"crossref","first-page":"30870","DOI":"10.1074\/jbc.273.47.30870","article-title":"Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells","volume":"273","author":"Li","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0080","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0085","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes","volume":"57","author":"Soro-Paavonen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cellimm.2021.104379_b0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2021.104379_b0095","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin, Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2021.104379_b0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2021.104379_b0110","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2021.104379_b0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE Signaling in Inflammatory Disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104379_b0120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/carcin\/bgp322","article-title":"Fueling inflammation at tumor microenvironment: the role of multiligand\/RAGE axis","volume":"31","author":"Rojas","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellimm.2021.104379_b0125","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00125-009-1458-9","article-title":"Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications","volume":"52","author":"Bierhaus","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.cellimm.2021.104379_b0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.ki.5002016","article-title":"Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation","volume":"71","author":"Boulanger","year":"2007","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.cellimm.2021.104379_b0135","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI11951","article-title":"Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)","volume":"108","author":"Oldfield","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2021.104379_b0140","doi-asserted-by":"crossref","first-page":"23233","DOI":"10.1074\/jbc.M110.117457","article-title":"Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages","volume":"285","author":"Xu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0145","doi-asserted-by":"crossref","first-page":"36330","DOI":"10.1074\/jbc.M706407200","article-title":"Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia\/ischemia","volume":"282","author":"Pichiule","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellimm.2021.104379_b0150","doi-asserted-by":"crossref","first-page":"L1427","DOI":"10.1152\/ajplung.00075.2007","article-title":"The role of the receptor for advanced glycation end-products in lung fibrosis","volume":"293","author":"He","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.cellimm.2021.104379_b0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2021.104379_b0160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging Biological Principles of Metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2021.104379_b0165","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cellimm.2021.104379_b0170","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.181.6.4272","article-title":"RAGE ligation affects T cell activation and controls T cell differentiation","volume":"181","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104379_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-14-12","article-title":"Effect of TTP488 in patients with mild to moderate Alzheimer's disease","volume":"14","author":"Burstein","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cellimm.2021.104379_b0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer\u2019s Disease","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.cellimm.2021.104379_b0185","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64671-8","article-title":"A precise and efficient stereological method for determining murine lung metastasis volumes","volume":"158","author":"Nielsen","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.cellimm.2021.104379_b0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/17469872.3.5.569","article-title":"Current concepts of metastasis in melanoma","volume":"3","author":"Zbytek","year":"2008","journal-title":"Expert Rev. Dermatol."},{"issue":"5","key":"10.1016\/j.cellimm.2021.104379_b0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI31422","article-title":"Altered macrophage differentiation and immune dysfunction in tumor development","volume":"117","author":"Sica","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104379_b0200","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1007\/s002800051101","article-title":"Biological implications of macrophage infiltration in human tumor angiogenesis","volume":"43","author":"Ono","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cellimm.2021.104379_b0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2021.104379_b0210","doi-asserted-by":"crossref","first-page":"107975","DOI":"10.1016\/j.exer.2020.107975","article-title":"Lysyl Oxidase Like 1: Biological roles and regulation","volume":"193","author":"Greene","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cellimm.2021.104379_b0215","first-page":"103","article-title":"Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease","volume":"6","author":"Ardizzoia","year":"1992","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.cellimm.2021.104379_b0220","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.cellimm.2021.104379_b0225","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104379_b0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104379_b0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104379_b0240","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","article-title":"Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells","volume":"181","author":"Sinha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104379_b0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.cellimm.2021.104379_b0250","doi-asserted-by":"crossref","first-page":"18985","DOI":"10.1074\/jbc.M111.313437","article-title":"Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells","volume":"287","author":"Mizumoto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2021.104379_b0260","first-page":"231","article-title":"RAGE is a Critical Mediator of Pulmonary Oxidative Stress","volume":"9","author":"Sanders","year":"2019","journal-title":"Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke, Sci Rep"},{"key":"10.1016\/j.cellimm.2021.104379_b0265","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1158\/0008-5472.CAN-13-2347","article-title":"HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells","volume":"74","author":"Parker","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104379_b0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.20070679","article-title":"RAGE signaling sustains inflammation and promotes tumor development","volume":"205","author":"Gebhardt","year":"2008","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104379_b0275","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4049\/jimmunol.1201151","article-title":"The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells","volume":"190","author":"Vernon","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104379_b0280","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2021.104379_b0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","article-title":"Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation","volume":"344","author":"Foell","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.cellimm.2021.104379_bib347","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jemt.10299","article-title":"S100A9\/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity","volume":"60","author":"Nacken","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104379_b0295","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.1202088","article-title":"Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8\/A9 proinflammatory proteins","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"issue":"44","key":"10.1016\/j.cellimm.2021.104379_bib348","doi-asserted-by":"crossref","first-page":"eaay6017","DOI":"10.1126\/sciimmunol.aay6017","article-title":"Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics","volume":"5","author":"Alshetaiwi","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellimm.2021.104379_b0305","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","article-title":"S100A8 and S100A9 in inflammation and cancer","volume":"72","author":"Gebhardt","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellimm.2021.104379_b0310","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cellimm.2021.104379_b0315","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.23099","article-title":"S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis","volume":"50","author":"Nemeth","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2021.104379_b0320","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.272.26.16498","article-title":"Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products","volume":"272","author":"Li","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0325","first-page":"1898","article-title":"Role of receptor for advanced glycation end products in the complication and progression of various types of cancers","volume":"2015","author":"Malik","year":"1850","journal-title":"Bba-Gen Subjects"},{"key":"10.1016\/j.cellimm.2021.104379_b0330","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","article-title":"Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective","volume":"60","author":"Bongarzone","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellimm.2021.104379_b0335","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2021.104379_b0340","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/onc.2016.324","article-title":"Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis","volume":"36","author":"Kwak","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cellimm.2021.104379_b0345","article-title":"The receptor RAGE: Bridging inflammation and cancer","volume":"7","author":"Riehl","year":"2009","journal-title":"Cell Commun. Signal."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:23:41Z","timestamp":1762107821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874921000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":69,"alternative-id":["S0008874921000988"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104379","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104379"}}